Sanjay Subramanian - Mar 31, 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Stock symbol
INZY
Transactions as of
Mar 31, 2023
Transactions value $
$2,164
Form type
4
Date filed
4/4/2023, 08:37 AM
Previous filing
Mar 27, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $2.16K +979 +3.61% $2.21 28.1K Mar 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of October 1, 2022 through March 31, 2023. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on October 3, 2022, the first trading day of the purchase period.